Evaluation of Symptoms Suspicious for GERD - Value of Endoscopy ⭐️Assess integrity of EGJ ⭐️ Several pitfalls of Hill classification! Consider using 🆕 AFS Endoscopic Classification of the Esophagogastric Junction Integrity! 🔗 journals.sagepub.com/doi/full/10.11… 🙏Dr Gyawali #EBMed

x.com/i/article/1923…

What is palliative care for #cirrhosis? 1. A strategy to support patients 2. Interventions proven to relieve symptoms 3. Tools proven to guide decisions 4. Complements the goals of transplant palliative care is not a referral. It is a strategy. A way of caring

🔍 Managing Fibrotic Strictures in Crohn’s Disease: What Are the Options? 1️⃣ Endoscopic Dilation ✅ First-line for short (<5 cm), uncomplicated strictures 💥 70–80% short-term relief 🔁 30–60% recurrence within 5 years ⚠️ Low complication rate (3–5%) ➡️ Ideal to delay surgery

🚨 New ACG Crohn’s Guidelines (2025) ▪️Scope at 6–12 mo post-op ▪️Early advanced therapy = key ▪️Anti-TNF, IL-23, JAKi > mesalamine ▪️High-risk = smoking, prior surgery, penetrating dz ▪️Surgery for abscess >2cm or strictures 🔗 bit.ly/acg-crohns-2025

📣#DrCynthiaYoshida taking the mystery out of abdominal pressure during colonoscopy ACG #EndoscopySchool 👉🏻Right Place 👉🏻Right Time

GLP-1RAs were associated with an increased risk of GERD and cholelithiasis but did not significantly increase the risk of pancreatitis, cholecystitis, intestinal obstruction, or other serious gastrointestinal or biliary events. GLP-1 RAs were associated with increased the risk

Summary of REDEFINE 1 and REDEFINE 2 trials with CagriSema, presented this week at #ADA2025 and published in NEJM: REDEFINE 1: • 👥 3,417 participants with obesity or overweight (without diabetes) treated with CagriSema achieved a 22.7% weight loss after 68 weeks, compared to

Forever grateful to BCM Gastroenterology for giving me the unique opportunity to train at a world-class institution and meet incredible mentors, peers, and people along the way. Proud to be a part of the first graduating class under PD Milena Gould Suarez, MD and looking forward to the future!

🚨 New Data on Risankizumab in Crohn’s Disease! Even initial nonresponders to IV induction saw benefits with extended treatment 💉 📈 At Week 24: ✅ Clinical Response: – 76% (180 mg SC) – 64% (360 mg SC) – 62% (1200 mg IV) ✅ Clinical Remission: Up to 45% ✅ Endoscopic

🔑ACG 2025 Preventive Care in IBD.Key Points: ✅ Vaccinations: - PCV20 or PCV21 instead of older schedules - Shingrix (2-dose recombinant) for all ≥50 yrs and ≥19 yrs if on immunosuppression - RSV vaccine for all ≥75 yrs & for 50–74 yrs w additional chronic conditions -

A must-read review in the NEJM on the most common cause of chronic liver disease: MASLD. All you need to know: trends, pathogenesis, early detection, co-morbidities, lifestyle changes and novel and future drugs….. shorturl.at/N88Ed

Proud to share the new C5 NYC PSA on colorectal cancer screening in Mandarin Chinese: bcove.video/4oz9Lot Hope this is will help our Chinese-speaking patients get screened! NYU Langone Health Memorial Sloan Kettering Cancer Center ACG American Gastroenterological Association (AGA) ASGE GI Endoscopy

Who better to kick off the Esophagus / Potpourri section than the motility maestro Walter Chan, MD, MPH discussing “Updates in Management of EOE” 🔹 PPI therapy in EoE - BID dosing > QD for histologic response - 10–12 weeks improves remission rates - Approx 68% maintain remission on

When we say GI is a small world, having the opportunity to invite #AhnNguyen my co-fellow from UTSW Gastro Hepatology Fellowship 📊 Acid control (Day 7 pH ≥4 time): •Vonoprazan: 85–94% •Esomeprazole: 61% •Rabeprazole: 65% •Lansoprazole: 42% ➡️ PCABs deliver faster, more potent acid

🚨 Big milestone in MASLD/MASH! We now have two FDA-approved drugs: 🔸 Resmetirom (oral, THR-β agonist) 🔹 Semaglutide (weekly SC, GLP-1 RA) I made this simple side-by-side comparison 👇

ACG guidelines on atrophic gastritis and gastric intestinal metaplasia 💡

📚 Functional GI Disorders – High-Yield Pearls (Dr. Rawan Dayah) 🧠 Hirschsprung Disease •❌ Absent RAIR (Rectoanal Inhibitory Reflex) → 🔍 Suggests Hirschsprung 🚽 Constipation •🌀 Colonic Inertia → ❌ No HAPCs (High-Amplitude Propagating Contractions) on manometry •🎈

Obesity is a chronic, relapsing disease, and effective medication use requires high-quality, evidence-based care. Our new quality indicators define best practices. Read more here: ow.ly/6V1450XpGZy Gastroenterology Carolyn Newberry MD Frederick Peng, MD, FACP, DABOM Jenny Maratt